Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis

Author(s): Uyttenhove C, Sommereyns C, Théate I, Michiels T, Van Snick J


Excessive or inappropriate production of IL-17A has been reported in diseases such as rheumatoid arthritis, asthma, and multiple sclerosis. The potential clinical relevance of these correlations was suggested by the protective effects of anti-IL-17A monoclonal antibodies in various mouse disease models. However, the chronic nature of the corresponding human afflictions raises great challenges for Ab-based therapies. An alternative to passive Ab therapy is autovaccination. Covalent association of self-cytokines with foreign proteins has been reported to induce the production of antibodies capable of neutralizing the biological activity of the target cytokine. We recently reported that cross-linking of IL-17A to ovalbumin produced highly immunogenic complexes that induced long-lasting IL-17A-neutralizing antibodies. Vaccinated SJL mice were completely protected against experimental autoimmune encephalomyelitis (EAE) induced by proteolipid protein peptide (PLP 139-151), and a monoclonal anti-IL-17A Ab (MM17F3), derived from C57Bl/6 mice vaccinated against IL-17A-OVA, also prevented disease development. Here we report that this Ab also protects C57Bl/6 mice from myelin oligdendrocyte glycoprotein (MOG)-induced EAE. Histological analysis of brain sections of C57Bl/6 mice treated with MM17F3 showed a complete absence of inflammatory infiltrates and evidence for a marked inhibition of chemokine and cytokine messages in the spinal cord. These results further extend the analytical and therapeutic potential of the autovaccine procedure.

Similar Articles

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

Author(s): Matusevicius D, Kivisäkk P, He B, Kostulas N, Ozenci V, et al.

Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis

Author(s): Hofstetter HH, Ibrahim SM, Koczan D, Kruse N, Weishaupt A, et al.

Suppression of experimental allergic encephalomyelitis in Rhesus monkeys by a synthetic basic copolymer

Author(s): Teitelbaum D, Webb C, Bree M, Meshorer A, Arnon R, et al.

The lineage decisions of helper T cells

Author(s): Murphy KM, Reiner SL

Lymphocyte responses and cytokines

Author(s): Paul WE, Seder RA

Mechanisms of action of glatiramer acetate in multiple sclerosis

Author(s): Neuhaus O, Farina C, Wekerle H, Hohlfeld R

Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis

Author(s): Kantengwa S, Weber MS, Juillard C, Benkhoucha M, Fellay B, et al.